Sildenafil Tablet
NDC Package 53746-351-90
Package Information
Sildenafil tablets is adultsSildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening [see Clinical Studies (14)]. This formulation utilizes a tablet delivery system. Marketed by Amneal Pharmaceuticals Of New York Llc, this product is identified by NDC 53746-351 and is authorized under FDA application ANDA202025.
Identification & Billing
- RxCUI: 577033 - sildenafil citrate 20 MG Oral Tablet
- RxCUI: 577033 - sildenafil 20 MG Oral Tablet
- RxCUI: 577033 - sildenafil 20 MG (as sildenafil citrate) Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 53746 - Amneal Pharmaceuticals Of New York Llc
- 53746-351 - Sildenafil
- 53746-351-90 - 90 TABLET in 1 BOTTLE
- 53746-351 - Sildenafil
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53746-351-90 identifies a specific commercial package of 90 tablet in 1 bottle of Sildenafil, a human prescription drug labeled by Amneal Pharmaceuticals Of New York Llc. This tablet is formulated for oral use and contains sildenafil citrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amneal Pharmaceuticals Of New York Llc on November 08, 2012. The current certification is valid through December 31, 2027.
How is this Amneal Pharmaceuticals Of New York Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53746035190. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.